Mrs. Mary Molina, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2570 Jensen Ave Ste 106, Sanger, CA 93657 Phone: 559-875-3428 Fax: 559-875-3434 |
Mrs. Shelly Tina Santoyo, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2570 Jensen Ave, Suite 106, Sanger, CA 93657 Phone: 559-875-3428 Fax: 559-875-3434 |
Miguel Alejandro Castro, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2570 Jensen Ave, Sanger, CA 93657 Phone: 559-875-3428 Fax: 559-875-3434 |
Carlos E Guzman, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 1822 Jensen Ave, Suite 101, Sanger, CA 93657 Phone: 559-875-5521 Fax: 559-875-2032 |
Ms. Cristina Lopez, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2570 Jensen Ave, Suite 102, Sanger, CA 93657 Phone: 559-876-1402 Fax: 559-876-9461 |
Blair London Frye, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 2502 Jensen Ave, Sanger, CA 93657 Phone: 559-875-6000 |
Joseph I Idoni, MPH, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 2535 Jensen Ave, Sanger, CA 93657 Phone: 559-876-6070 Fax: 559-876-6098 |
Sampath Wijesinghe, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 1393 Academy Ave, Sanger, CA 93657 Phone: 559-875-6900 |
News Archive
Scientists at the University of Granada and the High Resolution Hospital in Loja (Granada) prove that asthmatic patients who suffer from xerostomia (dry mouth syndrome) have a poorer level of control disease. Whether an asthmatic patient also suffers from severe xerostomia can be of great use for the pneumologist when it comes to establishing that particular patient's level of control disease.
An international team of researchers has developed a new mathematical tool that could help scientists to deliver more accurate predictions of how diseases, including COVID-19, spread through towns and cities around the world.
The Coalition for Pulmonary Fibrosis (CPF) has announced its annual awards honoring three critical areas of leadership that impact the work of the Pulmonary Fibrosis (PF) community.
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT technology, today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has determined that NexMed has evidenced compliance with the market value of listed securities requirement for continued listing on The NASDAQ Capital Market by evidencing a market capitalization in excess of $35 million for a minimum of ten consecutive trading days, in lieu of the $2.5 million in stockholder's equity as required by the Panel's decision dated December 17, 2009.
› Verified 4 days ago